Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Heather R. Ribaudo"'
Publikováno v:
HIV Clinical Trials. 11:351-358
Lower CD4+ T-cell counts are related to increased morbidity and mortality despite virologic suppression. CCR5 antagonists are associated with robust CD4+ T-cell responses. We examined the relationship of CCR5 antagonists to CD4+ T-cell gains.Meta-reg
Autor:
Schlomo Staszewski, Donna Mildvan, Julio S. G. Montaner, Heather R. Ribaudo, Robert T. Schooley, Raphael Dolin, Margaret A. Fischl, Camlin Tierney, John D. Hamilton, T. Creagh, Sunyoung Kim, M. Seligmann, Michael J. Daniels, Anastasios A. Tsiatis, David A. Cooper, David Katzenstein, Janet Darbyshire, Joseph J. Eron, Michael S. Saag, Abdel Babiker, James D. Neaton, A. Cross, Gary Collins, Christine Katlama, M. D. Hughes, Victor DeGruttola, Louis D. Saravolatz, Seth L. Welles, William A. O'Brien, Robert W. Coombs, Douglas D. Richman, Keith Henry, A. Breckenridge, Miklos Salgo, Pamela M. Hartigan, John Bartlett, Andrew M. Hill, Mark D. Moore, James G. Kahn, R.A. DeMasi, L. Struthers, Grossberg Se, Michael Hughes, D. Dawson, Scott M. Hammer
Publikováno v:
AIDS Research and Human Retroviruses. 16:1123-1133
Objective: To evaluate treatment-mediated changes in HIV-1 RNA and CD3 count as prognostic markers and surrogate end points for disease progression (AIDS/death). Methods: Data from 13,045 subjects in all 16 randomized trials comparing nucleoside anal
Autor:
Michael Hughes, Heather R. Ribaudo
Publikováno v:
The Journal of Infectious Diseases. 197:1084-1086
The question of when to start antiretroviral therapy (ART) for infection with HIV has been much discussed, and treatment management guidelines have oscillated from the “hit hard, hit early” philosophy to conservative approaches of deferring treat